Product logins

Find logins to all Clarivate products below.


Heart Valve Devices | Market Insights | Europe (Supplemental) | 2022

The European market for heart valve devices will grow through 2030, fueled by an expanding aging population and rising adoption of THV devices, reflecting the accumulation of favorable clinical data for the use of these devices for patient populations usually treated with surgical devices. However, the COVID-19 global pandemic will have a significant impact on the European heart valve devices market, resulting in lost procedure volumes in the short term followed by a period of recovery.

This Medtech 360 Report provides high-level market metrics for heart valve devices in Europe, including country-level data for major countries and aggregate data for the rest of Europe, across a 11-year period.

Related Medtech Insights Reports

Report
Heart Valve Devices – Market Insights – United States
The US heart valve device market continues to be driven by the introduction of novel products and key approvals for new indications of existing products. In particular, recent approvals of…
Report
Infusion Pumps – Market Insights – Europe
The European infusion pump demand will be underpinned by aging populations and rising chronic disease, while accelerating adoption of closed-loop, EHR-integrated smart pumps and growing demand of…
Report
Transcatheter Embolization and Occlusion Devices – Market Insights – Latin America
The Latin American TEO device market is poised to experience moderate growth through 2034. This growth will be driven by the introduction of newly developed technologies, increasing adoption of…
Report
Laparoscopic Devices – Market Insights – Europe
Laparoscopic procedure volumes in Europe will grow only modestly through 2034, with notable variation across procedure types. Bariatric and colorectal laparoscopic surgeries are expected to…
Report
Transcatheter Embolization and Occlusion Devices | Market Insights | Latin America (Supplemental) | 2023
Although COVID-19 has negatively impacted the Latin American transcatheter embolization and occlusion device market, the impact of COVID-19 has been limited. The market will expand at a modest rate…